Basit öğe kaydını göster

dc.contributor.authorKutuk, Meryem Ozlem
dc.contributor.authorTufan, Ali Evren
dc.contributor.authorGuler, Gulen
dc.contributor.authorYildirim, Veli
dc.contributor.authorToros, Fevziye
dc.date.accessioned2019-08-08T10:48:01Z
dc.date.available2019-08-08T10:48:01Z
dc.date.issued2016
dc.identifier.issn2053-8855
dc.identifier.urihttps://watermark.silverchair.com/omw017.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAmEwggJdBgkqhkiG9w0BBwagggJOMIICSgIBADCCAkMGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMSVinvLhwJblnQtyfAgEQgIICFDx0aQlQGoUGVWKpqdF5JWgQJCdh1p7si_zol3he1qe6WWVgyucgxtUMG6Dv3Rk-1QEbWOmskBbVo-a87MYn6jr9xF0VZn9zGfX0Me_u5HDpsU8qhUfBVwlU_PquXhJ3OWkdkoYxIuBI5ArXHC43RrS1mvg7Qnz3MvuTn28YB4We-JZFDizceXNrCHUKh0SvX143n_QvMHWBrxQNR5Q0eNgevKhUmuu8SwLHUMLaGKhIfq4aqfqE2pK8nN4CNanYAm8zAoSRwALus26ANezvEyCzCUjX_pIdXc_W6KUuwbOqidlS0UpBwUX_U4OtQrBfExJLUfhYmV2bTzjfZ8YIjvoSNDv5Hlddx6btXYfJGZ-vuhViLH9iCWpscD6B97FgeEiAuqWoKAEyVRy27SYpP5D4XK_zRWNASwdN1CIoJFp1r46YnRDQwjE-8FPlbzyxauzshTNAf1ISTEA81GzxctJJ_eFev5A32PIZ84TwXZVzOk0pH5bS4dk4M6JAZ6ALRsnElqulYXbGipY-3fx_s6Rq3wXNmPc63Pkz6igeYTkKnGR3NtZoDXH0qf1WlhhjjeqablbOC-ukzd7sM-wKN7VwT5AxDFMYO-1q-Pd9VC167OtsxNw39uFptxcQatkxBObPCngEyfcCJmVGntreZV3NL2ZHPbmHEQhl90RrqAsiz5ZmH9Jd8HPHppgk0q_ldsmbbrY
dc.identifier.urihttp://hdl.handle.net/11727/3844
dc.description.abstractOur case involves persistent hiccup arising in an adolescent with obsessive compulsive disorder (OCD) who was using aripiprazole as an augmentation to fluoxetine and whose hiccups remitted with dose reduction and rechallenge. Treatment suggested that aripiprazole might lead to hiccups. Antipsychotics are also used for the treatment of hiccups, but recent case reports suggest that they cause hiccups as well. Within 12 h of taking 5mg aripiprazole, the 13-year-old girl began having continuous hiccups, which lasted for 3-4 h. The hiccups resolved when the dose of aripiprazole was reduced to 2.5 mg. To achieve augmentation, aripiprazole was replaced with risperidone 0.5 mg/day for 1 month, but excess sedation was observed. As a result, aripiprazole was restarted at a dose of 2.5 mg/ day, and 1 week later, it was increased to 5 mg/every other day. No hiccups were observed.en_US
dc.language.isoengen_US
dc.relation.isversionof10.1093/omcr/omw017en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectSCHIZOPHRENIAen_US
dc.subjectRISPERIDONEen_US
dc.subjectPATIENTen_US
dc.titlePersistent hiccups due to aripiprazole in an adolescent with obsessive compulsive disorder responding to dose reduction and rechallengeen_US
dc.typearticleen_US
dc.relation.journalOXFORD MEDICAL CASE REPORTSen_US
dc.identifier.volume4en_US
dc.identifier.startpage66en_US
dc.identifier.endpage67en_US
dc.identifier.wos000377121100003en_US
dc.identifier.scopus2-s2.0-85007280117en_US
dc.contributor.pubmedID27099770en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster